Brian HicksPosted April 22, 2010
Promising results from phase III clinical trials could point to a bright future for Delcath Systems (NASDAQ:DCTH).
Brian HicksPosted April 22, 2010
Wealth Daily Editor Steve Christ takes a look at Blue Chip Stocks and explains why these household names will lead the next bull market
Brian HicksPosted April 21, 2010
Here's a video on the financial crisis that speaks for itself. It's the Congressional testimony of Bill Black, who may just be one of the biggest thorns in the side of folks that are pushing for a...
Christian DeHaemerPosted April 21, 2010
Wealth Daily Editor Christian DeHaemer talks about his favorite oil stock in an interesting historical context, and explains why you should buy today.
Brian HicksPosted April 20, 2010
Wealth Daily Editor Steve Christ takes a look at "Big Tobacco" and offers up a buy, sell, hold recommendation on Altria Group (NYSE:MO).
Brian HicksPosted April 20, 2010
The similarities between the Great Depression and our current economy seem too close to be believed. The findings from a 1930's Congressional commission in the wake of their disaster, show just how...
Brian HicksPosted April 20, 2010
A New Way To Trade FDA Decisions: The White Oak Docket
Luke BurgessPosted April 20, 2010
Newcrest Mining will build the largest underground mine in Australia, after approving the development of the large Cadia East gold-copper deposit located North of Sydney.
Brian HicksPosted April 19, 2010
Wealth Daily Editor Adam Sharp explains why biotech stocks are booming, and gives readers three picks worth taking a closer look at as this sector continues to gain steam.
Brian HicksPosted April 19, 2010
Billionaire investor Jim Rogers, Chairman of Rogers Holdings, feels a correction may be coming in the wake of the Goldman Sachs news, and he thinks it's overdue.
Brian HicksPosted April 17, 2010
Wealth Daily Editor Ian Cooper unveils what the ultimate contrarian indicator has to say, and offers two ways to trade it.
Luke BurgessPosted April 16, 2010
Wealth Daily Editor Luke Burgess tells investors how to profit from rising molybdenum prices through moly stocks.